{
    "clinical_study": {
        "@rank": "21907", 
        "brief_summary": {
            "textblock": "To evaluate and estimate the safety and efficacy of the combination of fluconazole and\n      flucytosine as treatment for acute cryptococcal meningitis in patients with AIDS.\n\n      Fluconazole and flucytosine have different mechanisms of action. Since fluconazole has not\n      been associated with hematologic suppression and does not produce renal impairment that can\n      result in higher serum flucytosine levels, this combination may be better tolerated than is\n      amphotericin B plus flucytosine."
        }, 
        "brief_title": "A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis.", 
        "condition": [
            "Meningitis, Cryptococcal", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Meningitis", 
                "Meningitis, Cryptococcal"
            ]
        }, 
        "detailed_description": {
            "textblock": "Fluconazole and flucytosine have different mechanisms of action. Since fluconazole has not\n      been associated with hematologic suppression and does not produce renal impairment that can\n      result in higher serum flucytosine levels, this combination may be better tolerated than is\n      amphotericin B plus flucytosine.\n\n      Patients in each cohort receive a lower dose of fluconazole alone or in combination with\n      flucytosine, or a higher dose of fluconazole alone. Doses in subsequent cohorts are\n      escalated if safety data in the previous cohort is satisfactory. Patients are evaluated\n      weekly for the first 4 weeks and every 2 weeks thereafter. Therapy continues until 8 weeks\n      after the CSF becomes culture negative, up to a maximum of 26 weeks."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Concurrent Medication:\n\n        Allowed:\n\n          -  Antiviral therapy (AZT, DHPG).\n\n          -  Prophylaxis for Pneumocystis carinii pneumonia.\n\n          -  Treatment for intercurrent opportunistic infection.\n\n        Concurrent Treatment:\n\n        Allowed:\n\n          -  Radiation therapy for mucocutaneous Kaposi's sarcoma.\n\n        Patients must have:\n\n          -  AIDS.\n\n          -  Evidence of Cryptococcal neoformans in culture or lumbar CSF OR clinical and CSF\n             findings compatible with cryptococcal meningitis.\n\n          -  No evidence of acute or chronic meningitis of any etiology other than cryptococcosis.\n\n          -  Life expectancy of at least 2 weeks.\n\n        Prior Medication:\n\n        Allowed:\n\n          -  Prior antiviral therapy (AZT, DHPG).\n\n          -  Prophylaxis for Pneumocystis carinii pneumonia.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following symptoms or conditions are excluded:\n\n          -  Relapsing on maintenance triazole therapy for cryptococcal meningitis.\n\n          -  Unable to take oral medication.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Concomitant use of any antifungal agent other than study drug.\n\n        Patients with the following prior conditions are excluded:\n\n        History of allergy to or intolerance of imidazoles, azoles, or flucytosine.\n\n        Prior Medication:\n\n        Excluded:\n\n          -  More than 1 mg/kg amphotericin B.\n\n          -  Systemic antifungal agents within 7 days prior to study entry."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "13 Years"
        }, 
        "enrollment": "64", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002113", 
            "org_study_id": "213A", 
            "secondary_id": "R-0202"
        }, 
        "intervention": [
            {
                "intervention_name": "Flucytosine", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Fluconazole", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Fluconazole", 
                "Flucytosine"
            ]
        }, 
        "keyword": [
            "Meningitis", 
            "Cryptococcosis", 
            "Drug Therapy, Combination", 
            "Fluconazole", 
            "Flucytosine", 
            "Acquired Immunodeficiency Syndrome"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90033"
                    }, 
                    "name": "Los Angeles County - USC Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orange", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92668"
                    }, 
                    "name": "UCI Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "921038681"
                    }, 
                    "name": "UCSD Med Ctr - Owen Clinic"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis.", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "reference": {
            "PMID": "7803641", 
            "citation": "Larsen RA, Bozzette SA, Jones BE, Haghighat D, Leal MA, Forthal D, Bauer M, Tilles JG, McCutchan JA, Leedom JM. Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis. 1994 Oct;19(4):741-5."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002113"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 1996"
    }, 
    "geocoordinates": {
        "Los Angeles County - USC Med Ctr": "34.052 -118.244", 
        "UCI Med Ctr": "33.788 -117.853", 
        "UCSD Med Ctr - Owen Clinic": "32.715 -117.157"
    }
}